Bioethics News

Tracking of Therapeutic Stem Cells Reveals No Cancer Risk

April 11, 2016

(Medical News Today) – Producing therapeutic stem cells does not lead to genetic changes related to cancer, according to research published in PLoS Genetics. This is encouraging news for those investigating the use of induced pluripotent stem (iPS) cells in the field of regenerative medicine. Pluripotent cells are stem cells that can generate all of the different cell types in the body.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.